The Medical Affairs Company (TMAC)
Medical Science Liaison, Oncology, Solid Tumor (South)
The Medical Affairs Company (TMAC), Granite Heights, Wisconsin, United States
Overview
Serving as a field-based extension of Medical Affairs, the Medical Science Liaison (MSL) will represent the Company, a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations. The MSL will initially support the Company’s lead product candidate, an orally available small molecule for the treatment of patients with locally advanced or metastatic solid tumors that have a TP53 Y220C mutation. The U.S. FDA has granted Fast Track designation for the treatment of cancer patients with locally advanced or metastatic solid tumors that have this mutation. Base pay
$180,000.00/yr - $200,000.00/yr Duties and Responsibilities
Establish Company as a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations. Maintain clinical, scientific, and technical expertise in relevant Oncology therapies and treatment areas. Collaborate with Medical Affairs, Clinical Operations, and other internal stakeholders, and serve as a Company resource to external stakeholders. Collaborate with clinical sites to enhance activities related to patient identification and enrollment into clinical trials, including identifying drivers and barriers to patient identification and enrollment; identifying patient journey/pathway through the clinical site and working with identified departments/referral centers to raise awareness of clinical trials and potential patient inclusion. Engage with investigators and site staff to ensure awareness of the Company’s clinical trial is maintained at a prominent level and is differentiated from competing protocols; ensure familiarity with all protocol and patient information. Provide investigators and site staff with relevant, compliant, and consistent medical and scientific support and communications. Develop and track KOL engagement plans – identify, develop, and maintain collaborative relationships with KOLs within the assigned region; participate in medical and scientific exchanges with the medical/scientific community. Facilitate research collaborations (including Investigator-Supported Trials) with key investigators by helping to identify, establish, and maintain such collaborations. Engage in speaker identification, training and evaluation and provide support for advisory board meetings as requested. Collaborate with Market Access and Commercial colleagues for thought leader and institutional engagement where appropriate. Qualifications
Advanced terminal degree strongly preferred (PharmD, PhD, DNP or MD). Will consider NP, MSN, or PA with Oncology and MSL experience. Minimum of 3+ years previous oncology MSL experience required (Breast, GYN, lung preferred). Minimum of 5+ years of clinical and/or research experience in Oncology required. Established relationships with Oncology KOLs and stakeholders at both academic institutions and community practices preferred. Ability to travel, locally and regionally, up to 60% with overnight stays required. Experience collaborating with payers of formulary committees preferred. Knowledge of FDA requirements and PhRMA Code, including regulations governing compliant scientific exchange required. Valid driver’s license. Salary notes
Salary offers to be determined based on industry experience, education and therapeutic expertise. Senioriy level
Associate Employment type
Full-time Job function
Science Industries
Medical Practices
#J-18808-Ljbffr
Serving as a field-based extension of Medical Affairs, the Medical Science Liaison (MSL) will represent the Company, a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations. The MSL will initially support the Company’s lead product candidate, an orally available small molecule for the treatment of patients with locally advanced or metastatic solid tumors that have a TP53 Y220C mutation. The U.S. FDA has granted Fast Track designation for the treatment of cancer patients with locally advanced or metastatic solid tumors that have this mutation. Base pay
$180,000.00/yr - $200,000.00/yr Duties and Responsibilities
Establish Company as a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations. Maintain clinical, scientific, and technical expertise in relevant Oncology therapies and treatment areas. Collaborate with Medical Affairs, Clinical Operations, and other internal stakeholders, and serve as a Company resource to external stakeholders. Collaborate with clinical sites to enhance activities related to patient identification and enrollment into clinical trials, including identifying drivers and barriers to patient identification and enrollment; identifying patient journey/pathway through the clinical site and working with identified departments/referral centers to raise awareness of clinical trials and potential patient inclusion. Engage with investigators and site staff to ensure awareness of the Company’s clinical trial is maintained at a prominent level and is differentiated from competing protocols; ensure familiarity with all protocol and patient information. Provide investigators and site staff with relevant, compliant, and consistent medical and scientific support and communications. Develop and track KOL engagement plans – identify, develop, and maintain collaborative relationships with KOLs within the assigned region; participate in medical and scientific exchanges with the medical/scientific community. Facilitate research collaborations (including Investigator-Supported Trials) with key investigators by helping to identify, establish, and maintain such collaborations. Engage in speaker identification, training and evaluation and provide support for advisory board meetings as requested. Collaborate with Market Access and Commercial colleagues for thought leader and institutional engagement where appropriate. Qualifications
Advanced terminal degree strongly preferred (PharmD, PhD, DNP or MD). Will consider NP, MSN, or PA with Oncology and MSL experience. Minimum of 3+ years previous oncology MSL experience required (Breast, GYN, lung preferred). Minimum of 5+ years of clinical and/or research experience in Oncology required. Established relationships with Oncology KOLs and stakeholders at both academic institutions and community practices preferred. Ability to travel, locally and regionally, up to 60% with overnight stays required. Experience collaborating with payers of formulary committees preferred. Knowledge of FDA requirements and PhRMA Code, including regulations governing compliant scientific exchange required. Valid driver’s license. Salary notes
Salary offers to be determined based on industry experience, education and therapeutic expertise. Senioriy level
Associate Employment type
Full-time Job function
Science Industries
Medical Practices
#J-18808-Ljbffr